Table 1.
SAMHD1 Variant | HIV-1 Restrictiona | Oligomerizationb | RNA Bindingc | Vpx Degradationd | dNTP Levele | Localizationf |
---|---|---|---|---|---|---|
WT | + | +++ | + | + | Low | N |
p.H123P | ND | − | + | − | ND | N + C |
p.R143C | ND | − | + | − | ND | N + C |
p.R143H | ND | − | + | − | ND | N + C |
p.R145Q | ND | − | + | + | ND | N + C |
p.H167Y | − | − | + | + | High | N + C |
p.1201 N | − | ++ | + | + | High | N + C |
p.G209S | + | +++ | + | + | Low | N |
p.F217C | − | − | + | + | High | N + C |
p.R226G | − | + | + | + | High | N + C |
p.M254V | − | +++ | + | − | High | N + C |
p.R290H | ND | − | + | + | ND | N + C |
p.D311A | − | +++ | + | + | High | N |
p.L369S | − | ++ | + | + | High | N + C |
p.M385V | − | − | + | − | High | N + C |
p.R442X | − | + | − | High | N + C | |
p.I448T | − | ++ | + | − | High | N + C |
p.Q548A | − | +++ | + | + | Low | N + C |
p.Q548X | − | − | + | − | High | N + C |
WT, wild type
ND, Not Determined
N, Nuclear; C, Cytoplasmic
Restriction was measured by infecting PMA-treated U937 cells stably expressing the indicated SAMHD1 (NM_015474.3) variants with HIV-1-GFP. After 48 h, the percentage of GFP-positive cells (infected cells) was determined by flow cytometry.
SAMHD1-FLAG variants were assayed for their ability to oligomerize, as described in Materials and Methods. “+++” indicates 100% oligomerization, which correspond to the amount of SAMHD1-HA that oligomerizes with wild type SAMHD1-FLAG; “++” indicates ~60% of binding; “+” indicates ~30% oligomerization; “−“ indicates that oligomerization was not detected.
SAMHD1-FLAG variants were assayed for their ability to interact with RNA as described in Materials and Methods. “+” is the binding achieved by wild type SAMHD1.
Vpx-dependent degradation of each human SAMHD1 polymorphism was determined as described in Materials and Methods. “+” indicates similar Vpx-mediated SAMHD1 degradation to the one observed for wild type SAMHD1; “−“indicates that degradation was not detected.
The cellular dNTP levels of U937 cells stably expressing the different SAMHD1 variants were determined as described in Materials and Methods. “High” indicates that SAMHD1 is unable to decrease the levels of dNTPs. ”Low” indicates similar dNTP levels to the ones observed for U937 cells stably expressing wild type SAMHD1.
Subcellular localization of SAMHD1 variants was determined as described in Materials and Methods and quantified (Supp. Table S1). “N” indicates nuclear localization; “C” indicates cytoplasmic localization; “N+C” indicates localization throughout the cell.